- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01819506
Patient Targeted Upper Extremity Rehabilitation After Stroke (TARG)
Patient-Targeted Upper Extremity Rehabilitation After Stroke
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The overwhelming majority of individuals who survive stroke have persistent upper extremity (UE) motor deficits which interfere with re-engagement in meaningful activities. While advances from neuroscience are spurring development of new rehabilitation strategies, the development of novel measurement methods has not kept pace. Currently, there is no comprehensive measurement framework to objectively quantify impairment, match a rehabilitation therapy program to a patient's impairment level, and measure specific therapy effects. Therefore there has not been a rehabilitation trial where a measurement framework is the basis for designing the treatment as well as defining the outcome. The investigators redesigned the Fugl-Meyer UE Assessment (FMA-UE) using item response theory Rasch analysis and developed a first of its kind measurement framework that locates a patient along a continuum of impairment and directs a personalized therapy program tailored to patients' specific impairments and ability levels. The purpose of this proposed research is to empirically test this framework.
The objective of this project is to empirically test the FMA-UE measurement framework.
This study hypothesizes that therapeutic task practice at the just-right challenge of difficulty will maximize post-stroke motor skill reacquisition. It is expected that "targeted task-practice", will increase UE motor ability because task goal difficulty will be matched and systematically progressed according to patients' initial and evolving levels of ability.
This is a single-blinded study with parallel arm design, stratified sampling and blocked randomization. 120 individuals with post-stroke UE hemiparesis will be enrolled; 40 participants per 3 UE impairment levels as defined by the investigators' measurement framework. Participants will engage in 12 sessions (3x/wk for 4 weeks, 2 hrs/session) of reach-to-grasp task-practice. Within each impairment level, subjects will be randomized to a treatment group; 20 to targeted task-practice and 20 to non-targeted task-practice. Targeted task-practice is personalized to patient-specific UE motor deficits with initial targets (goals) defined according to baseline measures and targets continually progressed after every 3 therapy sessions so that the goals match the patient's evolving level of ability. Non-targeted task practice is defined as a standard of care task-practice intervention intended to increase UE use but not alter specific impairments. Data analyses will include (1) ANOVA to test the effects of targeted vs. non-targeted therapy on UE motor ability, (2) multiple regression to model the relationship between therapy and movement adaptions occurring pre- to post-rehabilitation, and (3) growth mixture modeling to define responders and non-responders.
This project is significant because there is a pressing need for a comprehensive measurement framework to guide novel interventions designed to improve post-stroke UE motor function and define their effects.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
South Carolina
-
Charleston, South Carolina, Stati Uniti, 29401-5799
- Ralph H. Johnson VA Medical Center, Charleston, SC
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
Individuals are eligible for this study if they have:
- experienced a stroke at least 3 months prior that has resulted in unilateral hemiparesis.
- exhibit voluntarily paretic arm shoulder flexion 30 degrees with simultaneous elbow extension 20 degrees.
- impairment with overhead reach and wrist circumduction and fine motor dexterity.
- passive range of motion in affected shoulder, elbow and wrist within 20 degrees of normal values.
Exclusion Criteria:
Individuals are not eligible for this study if they have:
- a lesion in the brainstem or cerebellum.
- another neurological disease that may impair motor skills (e.g., Parkinson's Disease).
- pain in the affected upper extremity that would limit participation in the study intervention.
- difficulty understanding and following 3-step directions.
- difficulty sitting independently without postural support.
- an orthopedic condition or impaired corrected vision that alters the kinematics of reaching.
- are unable to travel to and remain in Charleston SC for the duration of the 4-week study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Targeted Task Practice
Targeted task practice is defined as a therapy program aimed at patient-specific upper extremity motor impairment levels and systematically progressed to assure an ongoing "just right" match between task-difficulty and patient-ability.
Participants attended occupational therapy 3 times per week for 4 weeks.
Each therapy session was 2 hours in length.
|
Similar to stroke rehabilitation occupational therapy.
Altri nomi:
|
|
Comparatore attivo: Non-Targeted Task Practice
Non-targeted task practice is a standard of care treatment consisting of task practice with no guidance from the measurement framework to systematically address specific upper extremity motor impairment levels or progress rehabilitation therapy.
Participants attended occupational therapy 3 times per week for 4 weeks.
Each therapy session was 2 hours in length.
|
Similar to stroke rehabilitation occupational therapy.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fugl-Meyer Assessment of the Upper Extremity
Lasso di tempo: participants will be followed for the duration of the 4-week rehabilitation treatment, an expected average of 4 weeks.
|
The Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a stroke rehabilitation assessment of arm/hand movement impairment.
It is traditionally scored by assigning 30 items assessing voluntary arm/hand movements and 3 items assessing reflexes an ordinal rating (0=unable, 1=partial, 2=near normal), then summing the ratings to obtain a general statement of ability.
Instead of this traditional scoring method, the investigators will eliminate the reflex items, thus reporting the aggregate score possible from 0/60 to 60/60 points.
Higher scores indicate greater levels of arm movement ability.
|
participants will be followed for the duration of the 4-week rehabilitation treatment, an expected average of 4 weeks.
|
|
Wolf Motor Function Test
Lasso di tempo: participants will be followed for the duration of the 4-week rehabilitation treatment, an expected average of 4 weeks.
|
The Wolf Motor Function Test is an assessment of arm movement function.
Subjects are timed (seconds) as they complete 15 functional movements with the paretic arm.
The average time required to complete an item is reported in seconds so that lower scores (quicker completion times) indicate greater functional movement skills.
Post-intervention averages were compared to baseline averages so a reduction in timed averages indicates improved movement function.
|
participants will be followed for the duration of the 4-week rehabilitation treatment, an expected average of 4 weeks.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Surface Electromyographic (sEMG) Analysis of Functional Arm Muscle Activations
Lasso di tempo: participants will be followed for the duration of the 4-week rehabilitation treatment, an expected average of 4 weeks.
|
sEMG analysis is an objective method to study muscle coordination during functional arm movements.
Subjects will be fitted with sensors on the skin placed over 8 arm/shoulder muscles on both arms.
The sensors will detect the muscle activity of these muscles during functional reaching movements.
sEMG data will be recorded with a 16-channel wireless Motion Labs EMG system and processed with custom ORBIS software.
|
participants will be followed for the duration of the 4-week rehabilitation treatment, an expected average of 4 weeks.
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: Michelle L. Woodbury, PhD, Ralph H. Johnson VA Medical Center, Charleston, SC
Pubblicazioni e link utili
Pubblicazioni generali
- Woodbury ML, Velozo CA, Richards LG, Duncan PW, Studenski S, Lai SM. Dimensionality and construct validity of the Fugl-Meyer Assessment of the upper extremity. Arch Phys Med Rehabil. 2007 Jun;88(6):715-23. doi: 10.1016/j.apmr.2007.02.036.
- Velozo CA, Woodbury ML. Translating measurement findings into rehabilitation practice: an example using Fugl-Meyer Assessment-Upper Extremity with patients following stroke. J Rehabil Res Dev. 2011;48(10):1211-22. doi: 10.1682/jrrd.2010.10.0203.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- N0799-R
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .